Johnson & Johnson has unveiled massive phase 3 survival data for its dual bispecific combination in earlier-line multiple ...

Helus Pharma said it completed enrollment ahead of schedule in the Phase 3 study evaluating HLP003 as an adjunctive treatment ...

ORIC Pharmaceuticals advances rinzimetostat into the global Phase 3 Himalayas-1 trial for mCRPC, with full global rights.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced topline results for the global Phase 3 SHASTA-3 and SHASTA-4 clinical studies of plozasiran in patients with severe hypertriglyceridemia ...

The results of two phase 3 trials suggest that investigational drug bepirovirsen reduces HBsAg production, helping the immune ...

Durham-based Atsena Therapeutics, a clinical-stage gene therapy company focused on using genetic medicine to reverse or prevent blindness, has dosed the first patient in the Phase 3 pivotal cohort of ...

Armata Pharmaceuticals is a Hold until Phase 3 AP-SA02 data, given a funding-dependent profile and limited margin for error.

Pivotal Phase 3 trial enrolls 850 patients, exceeding original projectionsStudy completion on track: symptomatic data readout - Q1 2027, ...

Feedback from the U.S. Food and Drug Administration (FDA) supports acceleration of OMT-28’s development path directly into a pivotal Phase 3 studyWith the vast majority of PMD patients having no ...

HLP003 previously granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration ("FDA”) HLP003 Phase 2 data demonstrated durable efficacy, with a mean ~23-po ...